Discover how N(9)-arenthenyl purines act as dual Src/Abl inhibitors targeting multiple kinase states to combat cancer drug resistance.
Discover how cancer cells use ABCB1 pumps to expel both chemotherapy drugs and their metabolites, creating powerful treatment resistance.
Explore the fascinating world of primate P-glycoprotein, a cellular guardian that protects our bodies from harmful substances and influences drug response.
Discover how slow-onset enzyme inhibition is revolutionizing antimalarial drug development against Plasmodium falciparum Enoyl-Acyl Carrier Protein Reductase.
Discover how chaetocin, a natural compound from fungi, shows promise in fighting drug-resistant non-small cell lung cancer by targeting transketolase and metabolic pathways.